RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..2 of 2 - per page
Order by
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
Injectables and oral medicines for hospital use
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
National Institute of Neurological Disorders and Stroke – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Pharmaceutical & Healthcare Annual Deals Analysis 2011
Mar 2011 - 107 pages - $3,500
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2010
Jan 2011 - 80 pages - $1,500
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011
Aug 2011 - 87 pages - $1,500
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2011
Apr 2011 - 89 pages - $1,500
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?
Mar 2011 - 6 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us